Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Reduced Incidence of Early Invasive Fungal Infection in Allogeneic Transplant Patients Following Micafungin Prophylaxis

Derek To, Dawn Warkentin, BSc(Pharm), PharmD, Raewyn Broady, MBChB, FRACP, Kevin Song, MD, Michael J. Barnett, BMBS, Donna L. Forrest, MD, Thomas J. Nevill, MD, FRCPC, Stephen H. Nantel, MD, FRCPC, John D. Shepherd, MD, FRCPC, Donna E. Hogge, MD, PhD, Cynthia L. Toze, MD, FRCPC, Sujaatha Narayanan, MD, Yasser Abou Mourad, MD, Heather J. Sutherland, MD, PhD, FRCPC, Maryse M. Power, MD, FRCPath

Blood (2011) 118 (21): 4567.

https://doi.org/10.1182/blood.V118.21.4567.4567

Published: 2011

Journal Articles

Elderly AML Patients Treated with Intensive Chemotherapy- Developing A Prognostic Scoring System. A Study On 381 Patients From British Columbia

Satish Krishnan, MBBS, MRCP, FRCPath, Huihua Li, Yasser R Abou Mourad, Michael J. Barnett, BMBS, Raewyn Broady, MBChB, FRACP, Donna L. Forrest, MD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, MD, Thomas J. Nevill, MD, FRCPC, Maryse M. Power, MD, FRCPath, John D. Shepherd, MD, FRCPC, Kevin W. Song, MD, Heather J. Sutherland, MD, PhD, FRCPC, Cynthia L. Toze, MD, FRCPC, Donna E. Hogge, MD, PhD

Blood (2011) 118 (21): 2561.

https://doi.org/10.1182/blood.V118.21.2561.2561

Published: 2011

Journal Articles

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Cynthia L. Toze, MD, FRCPC, Chinmay B. Dalal, MD, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Heather J. Sutherland, MD, PhD, FRCPC, Kevin W. Song, MD, Yasser Abou Mourad, MD, Raewyn Broady, MBChB, FRACP, Maryse M. Power, MD, FRCPath, Sujaatha Narayanan, MD, Tanya L. Gillan, PhD, FCCMG, Clayton A. Smith, MD, FRCPC, John D. Shepherd, MD, FRCPC

Blood (2011) 118 (21): 3100.

https://doi.org/10.1182/blood.V118.21.3100.3100

Published: 2011

Journal Articles

Clonal Evolution but Not Variant Chromosomal Translocations Is An Adverse Prognostic Marker for Cytogenetic Response and Survival in CML Patients Treated with Imatinib

Adisak Tantiworawit, MD, Yasser Abou Mourad, MD, Michael J Barnett, BMBS, Raewyn Broady, MBChB, FRACP, Donna E. Hogge, MD, PhD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, MD, Thomas J. Nevill, MD, FRCPC, Maryse M. Power, MD, FRCPath, John D. Shepherd, MD, FRCPC, Kevin W. Song, MD, Heather J. Sutherland, MD, PhD, FRCPC, Cynthia L. Toze, MD, FRCPC, Donna L. Forrest, MD

Blood (2011) 118 (21): 1694.

https://doi.org/10.1182/blood.V118.21.1694.1694

Published: 2011

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Eradication of Specific FISH Abnormalities with Relation to Gvhd and Transplant Outcomes.

Cynthia Toze, MD, FRCPC, Chinmay B. Dalal, MD, Tanya L. Gillan, PhD, FCCMG, Thomas J. Nevill, MD, FRCPC, Michael J. Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Donna E. Hogge, MD, PhD, Donna L. Forrest, MD, Heather Sutherland, MD, PhD, FRCPC, Kevin Song, MD, Raewyn Broady, MBChB, FRACP, Maryse Power, MD, FRCPath, Sujaatha Narayanan, MD, Clayton A. Smith, MD, FRCPC, John Shepherd

Blood (2010) 116 (21): 3465.

https://doi.org/10.1182/blood.V116.21.3465.3465

Published: 2010

Journal Articles

The Use of Novel Agents In Patients with Multiple Myeloma Initially Treated with Allogeneic Stem Cell Transplantation Results In A Significant Prolongation of Post Relapse Survival.

Christopher P. Venner, MD, Heather Sutherland, MD, PhD, FRCPC, John Shepherd, MD, FRCPC, Yasser Abou Mourad, MD, Michael J. Barnett, BMBS, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, MD, Thomas J. Nevill, MD, FRCPC, Janet Nitta, Maryse Power, MD, FRCPath, Cynthia Toze, MD, FRCPC, Clayton Smith, Kevin Song, MD

Blood (2010) 116 (21): 4580.

https://doi.org/10.1182/blood.V116.21.4580.4580

Published: 2010

Journal Articles

High Incidence of Invasive Fungal Infections in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation.

Winnie Ma, BSc(Pharm), Dawn Warkentin, BSc(Pharm), PharmD, Janice Yeung, BSc(Pharm), PharmD, John D Shepherd, MD, Yasser Abou Mourad, MD, Clayton Smith, MD, FRCPC, Kevin Song, MD, Donna E. Hogge, MD, PhD, Michael J Barnett, BMBS, Thomas J. Nevill, MD, FRCPC, Stephen H. Nantel, MD, FRCPC, Cynthia L. Toze, MD, FRCP(C), Heather J. Sutherland, MD, PhD, Donna L. Forrest, MD, Sujaatha Narayanan, MD, Maryse M Power, MD

Blood (2009) 114 (22): 1136.

https://doi.org/10.1182/blood.V114.22.1136.1136

Published: 2009

Journal Articles

Survival Outcome of Hematopoietic Stem Cell Transplant Recipients Admitted to the Intensive Care Unit: A Single-Center Report of 53 Patients

Jasbir K Jaswal, BSc, Sujaatha Narayanan, MD, MRCP, MRCPath, Kevin W Song, MD, FRCPC, Dean R Chittock, MD, MS (Epid), FRCPC, Donald E.G. Griesdale, MD, MPH, FRCPC

Blood (2008) 112 (11): 4303.

https://doi.org/10.1182/blood.V112.11.4303.4303

Published: 2008

Journal Articles

Predictors of Clinical Response in Patients with High Risk Acute Myeloid Leukemia Receiving Treatment with the Histone Deacetylase Inhibitor Sodium Valproate.

Charles Craddock, MD, PhD, Charlotte Bradbury, MD, Sujaatha Narayanan, MD, Adam Rye, MD, Supratik Basu, MD, Alan MacWhannell, MD, Alistair Sawers, MD, Mark Cook, MD, PhD, Michael Griffiths, MD, David Grimwade, MD, PhD, Christopher Bunce, PhD, Bryan Turner, PhD

Blood (2005) 106 (11): 2791.

https://doi.org/10.1182/blood.V106.11.2791.2791

Published: 2005

NARROW

Reduced Incidence of Early Invasive Fungal Infection in Allogeneic Transplant Patients Following Micafungin Prophylaxis

Elderly AML Patients Treated with Intensive Chemotherapy- Developing A Prognostic Scoring System. A Study On 381 Patients From British Columbia

Outcomes for Patients Aged 60 and Over Are Similar to Younger Patients Following Reduced-Intensity Allogeneic Stem Cell Transplant for CLL

Clonal Evolution but Not Variant Chromosomal Translocations Is An Adverse Prognostic Marker for Cytogenetic Response and Survival in CML Patients Treated with Imatinib

Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Eradication of Specific FISH Abnormalities with Relation to Gvhd and Transplant Outcomes.

The Use of Novel Agents In Patients with Multiple Myeloma Initially Treated with Allogeneic Stem Cell Transplantation Results In A Significant Prolongation of Post Relapse Survival.

High Incidence of Invasive Fungal Infections in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation.

Survival Outcome of Hematopoietic Stem Cell Transplant Recipients Admitted to the Intensive Care Unit: A Single-Center Report of 53 Patients

Predictors of Clinical Response in Patients with High Risk Acute Myeloid Leukemia Receiving Treatment with the Histone Deacetylase Inhibitor Sodium Valproate.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only